“The RE-UNITE-PN Study Design – A Prospective, Non-Interventional, Phase 4 Study of Nemolizumab for the Treatment of Prurigo Nodularis”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 2, Mar. 2026, p. s767, https://doi.org/10.25251/q0ctfz86.